| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 1.11e-05 | 329 | 67 | 8 | GO:0018212 | |
| MousePheno | increased CD8-positive, alpha-beta T cell number | 1.06e-05 | 195 | 55 | 7 | MP:0008078 | |
| MousePheno | optic neuropathy | 1.52e-05 | 2 | 55 | 2 | MP:0006222 | |
| MousePheno | increased effector memory CD8-positive, alpha-beta T cell number | 8.31e-05 | 59 | 55 | 4 | MP:0010850 | |
| MousePheno | increased plasmacytoma incidence | 9.07e-05 | 4 | 55 | 2 | MP:0010286 | |
| Domain | IgC2-like_lig-bd | 7.35e-05 | 4 | 66 | 2 | IPR010457 | |
| Domain | Lep_receptor_Ig | 7.35e-05 | 4 | 66 | 2 | PF06328 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 2.55e-04 | 7 | 66 | 2 | IPR003529 | |
| Domain | Znf_MYM | 2.55e-04 | 7 | 66 | 2 | IPR010507 | |
| Domain | zf-FCS | 2.55e-04 | 7 | 66 | 2 | PF06467 | |
| Domain | TRASH_dom | 3.40e-04 | 8 | 66 | 2 | IPR011017 | |
| Domain | TRASH | 3.40e-04 | 8 | 66 | 2 | SM00746 | |
| Domain | HEMATOPO_REC_L_F2 | 3.40e-04 | 8 | 66 | 2 | PS01353 | |
| Domain | Linker_histone | 9.36e-04 | 13 | 66 | 2 | PF00538 | |
| Domain | Histone_H1/H5_H15 | 1.09e-03 | 14 | 66 | 2 | IPR005818 | |
| Domain | Lactamase_B | 1.25e-03 | 15 | 66 | 2 | SM00849 | |
| Domain | - | 2.24e-03 | 20 | 66 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 2.24e-03 | 20 | 66 | 2 | IPR001279 | |
| Domain | - | 2.56e-03 | 391 | 66 | 6 | 2.30.29.30 | |
| Domain | PH_dom-like | 3.90e-03 | 426 | 66 | 6 | IPR011993 | |
| Domain | DEATH | 4.08e-03 | 27 | 66 | 2 | SM00005 | |
| Domain | TNFR_NGFR_1 | 4.70e-03 | 29 | 66 | 2 | PS00652 | |
| Domain | TNFR_NGFR_2 | 4.70e-03 | 29 | 66 | 2 | PS50050 | |
| Domain | Death | 6.05e-03 | 33 | 66 | 2 | PF00531 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 6.05e-03 | 33 | 66 | 2 | IPR001368 | |
| Pubmed | 8.49e-07 | 10 | 68 | 3 | 17506816 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.16e-06 | 588 | 68 | 9 | 38580884 | |
| Pubmed | Autophagy Differentially Regulates Insulin Production and Insulin Sensitivity. | 3.77e-06 | 2 | 68 | 2 | 29898399 | |
| Pubmed | Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen. | 3.77e-06 | 2 | 68 | 2 | 21830209 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 26076811 | ||
| Pubmed | Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice. | 3.77e-06 | 2 | 68 | 2 | 25911755 | |
| Pubmed | Roles of PLC-gamma2 and PKCalpha in TPA-induced apoptosis of gastric cancer cells. | 3.77e-06 | 2 | 68 | 2 | 14606067 | |
| Pubmed | 9.27e-06 | 21 | 68 | 3 | 19015235 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 33354817 | ||
| Pubmed | The stability of Fbw7α in M-phase requires its phosphorylation by PKC. | 1.13e-05 | 3 | 68 | 2 | 28850619 | |
| Pubmed | Tissue factor binds to and inhibits interferon-α receptor 1 signaling. | 1.13e-05 | 3 | 68 | 2 | 38141610 | |
| Pubmed | Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. | 1.13e-05 | 3 | 68 | 2 | 15611291 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 18198209 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 36229563 | ||
| Pubmed | A mosquito salivary protein promotes flavivirus transmission by activation of autophagy. | 1.13e-05 | 3 | 68 | 2 | 31937766 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 39168127 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10486218 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 27556506 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10666256 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 20350647 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 19324870 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 32116109 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 21156808 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23434935 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 21389833 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 39052479 | ||
| Pubmed | Paneth cell TNF signaling induces gut bacterial translocation and sepsis. | 1.13e-05 | 3 | 68 | 2 | 39243761 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 37428632 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 31712385 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23070544 | ||
| Pubmed | Plakophilin 2: a critical scaffold for PKC alpha that regulates intercellular junction assembly. | 1.13e-05 | 3 | 68 | 2 | 18474624 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24307739 | ||
| Pubmed | Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes. | 1.13e-05 | 3 | 68 | 2 | 34348155 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 23401860 | ||
| Pubmed | Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways. | 2.25e-05 | 4 | 68 | 2 | 16923831 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 15661932 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 9398617 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 34709350 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 16303847 | ||
| Pubmed | FLNB ANK2 CLPB DSP N4BP2L2 NCKAP5 BECN1 NEUROD6 NIPBL TARBP1 ZMYM4 | 3.72e-05 | 1285 | 68 | 11 | 35914814 | |
| Pubmed | Insulin action and resistance are dependent on a GSK3β-FBXW7-ERRα transcriptional axis. | 3.75e-05 | 5 | 68 | 2 | 35440636 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 19423708 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 30282750 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 32870819 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 16237096 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 28380351 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 20815813 | ||
| Pubmed | MAIT cell activation augments adenovirus vector vaccine immunogenicity. | 5.62e-05 | 6 | 68 | 2 | 33510029 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 18184798 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 23623383 | ||
| Pubmed | Two sequential activation modules control the differentiation of protective T helper-1 (Th1) cells. | 5.62e-05 | 6 | 68 | 2 | 33773107 | |
| Pubmed | Identification of an elaborate complex mediating postsynaptic inhibition. | 5.62e-05 | 6 | 68 | 2 | 27609886 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 5.93e-05 | 1353 | 68 | 11 | 29467282 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 27756058 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 29695787 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 35143611 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 24747678 | ||
| Pubmed | Mature B cells and mesenchymal stem cells control emergency myelopoiesis. | 7.86e-05 | 7 | 68 | 2 | 36717247 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 26259586 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 38788712 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 31444264 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 15351786 | ||
| Pubmed | 8.96e-05 | 119 | 68 | 4 | 23508102 | ||
| Pubmed | FLNB IQSEC3 ANK2 DSP MYO9A TLN1 TRAPPC10 OTUD4 ELP1 PRKCA HP1BP3 | 9.77e-05 | 1431 | 68 | 11 | 37142655 | |
| Pubmed | GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity. | 1.05e-04 | 8 | 68 | 2 | 27927647 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 11714812 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 34131310 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 10094049 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 32075762 | ||
| Pubmed | RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. | 1.05e-04 | 8 | 68 | 2 | 24813850 | |
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 33510463 | ||
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 20333651 | ||
| Pubmed | Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity. | 1.34e-04 | 9 | 68 | 2 | 29212904 | |
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 31959883 | ||
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 11807098 | ||
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 17051153 | ||
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 12444124 | ||
| Pubmed | In silico prediction of physical protein interactions and characterization of interactome orphans. | 1.50e-04 | 136 | 68 | 4 | 25402006 | |
| Pubmed | ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1. | 1.68e-04 | 10 | 68 | 2 | 31358656 | |
| Pubmed | OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity. | 1.68e-04 | 10 | 68 | 2 | 34625556 | |
| Pubmed | Interferon b drives intestinal regeneration after radiation. | 1.68e-04 | 10 | 68 | 2 | 34613772 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 29805094 | ||
| Pubmed | CD8+ T cells induce cachexia during chronic viral infection. | 1.68e-04 | 10 | 68 | 2 | 31110314 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 10442092 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 20080755 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 16670325 | ||
| Pubmed | Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. | 2.05e-04 | 11 | 68 | 2 | 18368052 | |
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 22980983 | ||
| Pubmed | Divergent Role for STAT5 in the Adaptive Responses of Natural Killer Cells. | 2.45e-04 | 12 | 68 | 2 | 33326784 | |
| Pubmed | 2.49e-04 | 638 | 68 | 7 | 31182584 | ||
| Pubmed | KLHL6 FLNB MASTL TRAPPC10 OTUD4 N4BP2L2 CEP295 FAM135A LMBRD1 | 2.54e-04 | 1084 | 68 | 9 | 11544199 | |
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 2.90e-04 | 13 | 68 | 2 | 22878500 | |
| Pubmed | TNF-α sculpts a maturation process in vivo by pruning tolerogenic dendritic cells. | 2.90e-04 | 13 | 68 | 2 | 35417681 | |
| Pubmed | A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis. | 2.90e-04 | 13 | 68 | 2 | 22588081 | |
| Pubmed | Proximity labeling reveals OTUD3 as a DNA-binding deubiquitinase of cGAS. | 3.27e-04 | 68 | 68 | 3 | 36966392 | |
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 26720279 | ||
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 22840842 | ||
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 22815848 | ||
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 18715339 | ||
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 19380791 | ||
| Interaction | NOX1 interactions | 9.81e-06 | 13 | 67 | 3 | int:NOX1 | |
| Cytoband | 6q13 | 1.55e-03 | 39 | 68 | 2 | 6q13 | |
| Cytoband | 1p36.12 | 1.55e-03 | 39 | 68 | 2 | 1p36.12 | |
| GeneFamily | Zinc fingers MYM-type | 7.12e-05 | 6 | 40 | 2 | 86 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TDRD7 BCLAF3 DSP MYO9A CENPI ERCC6L2 MASTL OTUD4 CEP295 PLCG2 FAM135A ZMYM6 FBXW7 | 1.42e-06 | 820 | 67 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 3.19e-06 | 72 | 67 | 5 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 6.33e-05 | 68 | 67 | 4 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_200 | 1.03e-04 | 29 | 67 | 3 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.40e-04 | 361 | 67 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.51e-04 | 85 | 67 | 4 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | CCNG1 MYO9A ERCC6L2 N4BP2L2 NEIL3 NIPBL ZMYM4 HP1BP3 FBXW7 IFNAR1 | 1.57e-04 | 780 | 67 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.70e-07 | 200 | 67 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.66e-06 | 180 | 67 | 5 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | B_cells-Plasmablasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.70e-06 | 189 | 67 | 5 | 87cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6 | |
| ToppCell | Sigmoid-(2)_B_cell|Sigmoid / shred on region, Cell_type, and subtype | 1.24e-05 | 199 | 67 | 5 | 646960845ede4c5b00cdfe73051d5d4577648bf8 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 199 | 67 | 5 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Sigmoid-B_cell|Sigmoid / Region, Cell class and subclass | 1.24e-05 | 199 | 67 | 5 | 997ee1b622b1e349d5e98026afbc4f8d283b2136 | |
| ToppCell | Sigmoid-(2)_B_cell-(20)_B_cell_IgA_Plasma|Sigmoid / shred on region, Cell_type, and subtype | 1.24e-05 | 199 | 67 | 5 | f3c583f8521f63834d1afbf8b07940fee7712f9a | |
| ToppCell | Sigmoid-B_cell-B_cell_IgA_Plasma|Sigmoid / Region, Cell class and subclass | 1.24e-05 | 199 | 67 | 5 | 634e0b614ab45e7520da67375b3498db5442b7ae | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 200 | 67 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-05 | 156 | 67 | 4 | bb64bf520cb74897a01c64924a85a1550df2b801 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.12e-04 | 165 | 67 | 4 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-04 | 166 | 67 | 4 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 167 | 67 | 4 | 0130743084dbcb20e10f96715d30961122150cbf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 167 | 67 | 4 | 7bcae3797d3a0811e7f39885afdfd29ec517f11b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 167 | 67 | 4 | c6f0209a1ad797631fdfa3efab6db6b1d3e8e315 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.20e-04 | 168 | 67 | 4 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 1.43e-04 | 176 | 67 | 4 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.53e-04 | 179 | 67 | 4 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 1.59e-04 | 181 | 67 | 4 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-04 | 181 | 67 | 4 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-04 | 181 | 67 | 4 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.66e-04 | 183 | 67 | 4 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-04 | 184 | 67 | 4 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-04 | 184 | 67 | 4 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.73e-04 | 185 | 67 | 4 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 186 | 67 | 4 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 191 | 67 | 4 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-04 | 191 | 67 | 4 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.96e-04 | 191 | 67 | 4 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.96e-04 | 191 | 67 | 4 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 192 | 67 | 4 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 193 | 67 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 193 | 67 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 193 | 67 | 4 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 193 | 67 | 4 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 2.04e-04 | 193 | 67 | 4 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.04e-04 | 193 | 67 | 4 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-04 | 194 | 67 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 194 | 67 | 4 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 194 | 67 | 4 | 06b8dc2e46f833707d5b68b324b4ff6c4d0dccf9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.12e-04 | 195 | 67 | 4 | cc3d6f98d310e8840ff497d7258c5ccf54e6c624 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 197 | 67 | 4 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-04 | 198 | 67 | 4 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-04 | 198 | 67 | 4 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-04 | 198 | 67 | 4 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Sigmoid|World / shred on region, Cell_type, and subtype | 2.29e-04 | 199 | 67 | 4 | 83737cf4e511e660ec2d268447228cefc8a7ba9c | |
| ToppCell | Transverse-B_cell|Transverse / Region, Cell class and subclass | 2.29e-04 | 199 | 67 | 4 | 91ac70fe1f351eb7ee3600a17120cd1301220041 | |
| ToppCell | Transverse-(2)_B_cell|Transverse / shred on region, Cell_type, and subtype | 2.29e-04 | 199 | 67 | 4 | fcdea790d2b34efac8ce80a296db54916ab621cb | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-04 | 199 | 67 | 4 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-04 | 199 | 67 | 4 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | Transverse-(2)_B_cell-(20)_B_cell_IgA_Plasma|Transverse / shred on region, Cell_type, and subtype | 2.29e-04 | 199 | 67 | 4 | 8caaa08b046f766af298d03961ccac6e4569e2a6 | |
| ToppCell | Caecum-(2)_B_cell-(20)_B_cell_IgA_Plasma|Caecum / shred on region, Cell_type, and subtype | 2.29e-04 | 199 | 67 | 4 | 76b3c2ee5da8ddc214e5919b5804dfedcbb60d30 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-04 | 199 | 67 | 4 | 58242d78517c05fa367a7c6edac57ef79107453c | |
| ToppCell | Caecum-B_cell-B_cell_IgA_Plasma|Caecum / Region, Cell class and subclass | 2.29e-04 | 199 | 67 | 4 | 49c19601566205f41f04bfb5714f865398482d39 | |
| ToppCell | Transverse-B_cell-B_cell_IgA_Plasma|Transverse / Region, Cell class and subclass | 2.29e-04 | 199 | 67 | 4 | ea65cadaf464ff4c1040fceb5f3724706f8447c1 | |
| ToppCell | Sigmoid|World / Region, Cell class and subclass | 2.29e-04 | 199 | 67 | 4 | 5b05ba8d24b33e88800777cf2cb0d5a6c8eea1d7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 2.29e-04 | 199 | 67 | 4 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 200 | 67 | 4 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 200 | 67 | 4 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 200 | 67 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 200 | 67 | 4 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 200 | 67 | 4 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 200 | 67 | 4 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 2.33e-04 | 200 | 67 | 4 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 2.33e-04 | 200 | 67 | 4 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 200 | 67 | 4 | e1b3fc516887510b18cf688ada0e00b5f5eff684 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 200 | 67 | 4 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.33e-04 | 200 | 67 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 2.47e-04 | 203 | 67 | 4 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.12e-06 | 183 | 67 | 7 | 2750_DN | |
| Disease | breast carcinoma, hormone replacement therapy | 1.48e-05 | 3 | 66 | 2 | EFO_0000305, EFO_0003961 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.24e-04 | 43 | 66 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | response to carboplatin, response to antineoplastic agent | 2.19e-04 | 10 | 66 | 2 | GO_0097327, GO_0097328 | |
| Disease | breast cancer (biomarker_via_orthology) | 3.78e-04 | 13 | 66 | 2 | DOID:1612 (biomarker_via_orthology) | |
| Disease | ovarian carcinoma (is_implicated_in) | 5.08e-04 | 15 | 66 | 2 | DOID:4001 (is_implicated_in) | |
| Disease | schizophrenia (biomarker_via_orthology) | 5.08e-04 | 15 | 66 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 6.56e-04 | 17 | 66 | 2 | DOID:11984 (is_marker_for) | |
| Disease | ischemia (biomarker_via_orthology) | 7.37e-04 | 18 | 66 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.36e-03 | 97 | 66 | 3 | DOID:3083 (is_marker_for) | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 1.53e-03 | 221 | 66 | 4 | C0011860 | |
| Disease | Depressive Symptoms | 1.55e-03 | 26 | 66 | 2 | C0086132 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.79e-03 | 28 | 66 | 2 | DOID:8634 (is_marker_for) | |
| Disease | ovarian carcinoma (is_marker_for) | 1.79e-03 | 28 | 66 | 2 | DOID:4001 (is_marker_for) | |
| Disease | Streptozotocin Diabetes | 1.85e-03 | 108 | 66 | 3 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.85e-03 | 108 | 66 | 3 | C0011853 | |
| Disease | Alloxan Diabetes | 1.85e-03 | 108 | 66 | 3 | C0002152 | |
| Disease | muscular atrophy (biomarker_via_orthology) | 1.92e-03 | 29 | 66 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | mean platelet volume | 1.93e-03 | 1020 | 66 | 8 | EFO_0004584 | |
| Disease | proteinuria (implicated_via_orthology) | 2.06e-03 | 30 | 66 | 2 | DOID:576 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSYLSCKSETEVKKV | 126 | Q93088 | |
| TSSALPVKCYSKPFK | 361 | Q5JVX7 | |
| DQKDTTPYSSKLLKS | 256 | Q96GX5 | |
| PKTCSTTALKKYVLE | 356 | Q5SSJ5 | |
| YATVSSPSKSKKLEC | 541 | Q01804 | |
| SDDSNLYLTASKKKP | 241 | Q9BZG1 | |
| KSTGVQTSPDLKKCY | 101 | Q6ZSG2 | |
| SLDSKTKCPVKTRSY | 3396 | Q01484 | |
| SKCLTEYSSNKCSKP | 246 | P51959 | |
| LATDKTQCYDPSTNK | 481 | Q8WZ60 | |
| AIKTPQCYKEDGSSK | 296 | Q7L5Y9 | |
| KPKTAQYSSPELKSC | 466 | Q8TAT5 | |
| TSKCTQIKTALKYTL | 131 | Q9NUN5 | |
| KICNKSSSAYTPLKC | 286 | Q68D85 | |
| AKCKAKSLSPGLAYT | 16 | Q6ZT52 | |
| NSTCAKKYPIAEEKT | 671 | Q99665 | |
| SLTDKSKELPLYCSG | 341 | Q14457 | |
| ESPCNVKYSSKSKFD | 1161 | Q9P2D6 | |
| CYSAIPKASSDASKV | 2501 | O75369 | |
| KLSPETTYCLKVKAA | 191 | P17181 | |
| KSINNDTTYCIKKLP | 91 | Q53H82 | |
| DSSYKPVKKACTQLV | 1961 | Q6KC79 | |
| KCFSSKNSPLKDSFS | 1011 | P48357 | |
| YLKQSLSFSTCGKSK | 331 | O95163 | |
| SDLVVYCKPTSKTKD | 931 | P16885 | |
| KLCPKKKSSSTYTFC | 906 | Q9UPP2 | |
| PFKSHKSCSPSYKLL | 691 | Q9NYA4 | |
| EITTYKKKLSTNQPC | 786 | Q9NY74 | |
| SSYCSEPTLLKKANK | 431 | Q96NX5 | |
| PFKPSKKDSIACTYS | 341 | A2AJT9 | |
| KPLCRSSQSTEPKYK | 356 | Q96SD1 | |
| AGCPSYDKLLSAKNK | 181 | Q9Y223 | |
| DTSSYAKILTCPKTK | 2766 | P15924 | |
| KIATTKYPCLKSSGE | 51 | Q6UXH8 | |
| FSLGKKPCKVSEYTS | 181 | Q969H0 | |
| CYSKSPSNKDAALLE | 126 | Q9H078 | |
| PANIAVCSSKTYKEK | 1166 | Q5T890 | |
| CKYVSLATLKKAVST | 131 | P60008 | |
| PVLNSSSYTKECGKK | 311 | Q92674 | |
| AEAKPKSTCELYSSQ | 1661 | Q9C0D2 | |
| SYSESSPDLKKCIKS | 1571 | P56715 | |
| TSQCLKKNSKERPTY | 291 | P52564 | |
| CKVSSKNIKSPRYSV | 571 | Q9P2B2 | |
| LTQAKCKASYPLKIT | 166 | Q8NHM4 | |
| SYPKSLSKEAVSVCK | 556 | P17252 | |
| IKSSSLKEYPPCKTA | 441 | O14513 | |
| KPLDSSVLQFSSKYK | 551 | Q8TE76 | |
| EKSKAYKLNPKFCSL | 556 | Q8NHU6 | |
| AYTPKLIKAKSTKCF | 301 | Q8TEV9 | |
| CNKDPFTLKSSVYLS | 156 | O60704 | |
| PLAAAKKLCTLAQSY | 1006 | Q6ZVD8 | |
| LQKSPSTSCLYGKKL | 1226 | Q6ZVD8 | |
| ALQCSPSDAYTKKEL | 1936 | Q9Y490 | |
| EYCLNSSKNKITKAP | 451 | Q8IV35 | |
| LPKLTNNCSDESLYK | 11 | Q6ZNM6 | |
| PKSAAICYTAALLKT | 361 | Q8TDW4 | |
| KKPSALVSDSALYFC | 96 | A0A0B4J244 | |
| CSQSCLSSYELKKKP | 166 | O95789 | |
| QEKKPESSGYKELSC | 751 | Q9NPG3 | |
| TAKSLDLTQYCFPEK | 1546 | Q13395 | |
| TAQSPYKKLKEALSS | 436 | P48553 | |
| SCKYLAVPTSKKKET | 106 | P17948 | |
| LVTTKTNDYCKSLPA | 156 | Q02223 | |
| SKLYSIVCGKSTPEK | 241 | P19438 | |
| SCITAYKQKSAKITP | 516 | Q5VZL5 | |
| KPSSLAQKEYLSQSC | 1696 | Q5THJ4 | |
| SKTFLKKNSCYTLLE | 1086 | P41229 | |
| PRCKKLKSTTESYVF | 21 | Q92802 | |
| AKCSKKYDPELSSRQ | 2046 | B2RTY4 | |
| VPCYSKTQKLSKIET | 121 | Q96NK8 |